Effectiveness of Abdominal Binder Use During Colonoscopy
Performance and Tolerance of Colonoscopy
Bottom Line
View on ClinicalTrials.gov: NCT04383132 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Abdominal Binder (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
- Primary completion
- Aug 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Cecal Intubation Time |
240; 250 | 0.388 |
| SECONDARY Number of Participants Who Required Ancillary Maneuvers |
65; 85 | 0.069 |
| SECONDARY Length of Cecal Intubation |
89; 88.5 | 0.487 |
| SECONDARY Number of Participants Who Completed the Procedure |
169; 168 | 0.822 |
| SECONDARY Number of Participants Who Required Additional Anesthetic and / or Analgesic Drug |
43; 64 | 0.016 sig |
| SECONDARY Patient Pain and Comfort Level at Discharge |
1.9; 3.3; 1.7; 1.7 | 0.001 sig |
| SECONDARY Number of Participants According to Colonoscopy Findings |
72; 70; 60; 59; 38; 42 | 0.184 |
Summary
Eligibility Criteria
Inclusion Criteria
Between the ages of 18 - 90 Participants must have completed the full prescribed colonoscopy purgative preparation prior to their procedure, and describe adequate cleansing.
Participants with ASA I-III (American Society of Anesthesiologists Class III)
Exclusion Criteria
Previous colon resection History of intra-abdominal malignancy Known anesthetic or analgesic drugs allergy Multiple planned procedures (e.g.bidirectional endoscopy) Pregnancy Active inflammatory bowel disease A history of intraabdominal malignancy History of cirrhosis or ascites Known ventral hernia
Data sourced from ClinicalTrials.gov (NCT04383132). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.